Showing results (1-10 of 130) with videos related to
Sort By:
Pageof 13
Arthritis Research|November 30, 2000
What you should know about PR3-ANCA. Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCAU SpecksCurrent Opinion in Rheumatology|January 27, 2000
Are animal models of vasculitis suitable tools?U SpecksRheumatic Diseases Clinics of North America|November 29, 2001
Are antineutrophil cytoplasmic antibodies pathogenic? Experimental approaches to understand the antineutrophil cytoplasmic antibody phenomenonK A Russell, U SpecksMonographs in Pathology|January 1, 1993
Wegener's granulomatosis in the 1990s--a pulmonary pathologist's perspectiveT V Colby, U SpecksRheumatic Diseases Clinics of North America|May 1, 1990
Granulomatous vasculitis. Wegener's granulomatosis and Churg-Strauss syndromeU Specks, R A DeRemeeJournal of Immunological Methods|May 10, 1996
Microtiter plate immunoassay for the evaluation of platelet adhesion to fibronectinM Chiba, S W Malik, U SpecksArthritis and Rheumatism|March 7, 2001
Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitisK A Russell, D N Fass, U SpecksClinical and Experimental Immunology|August 1, 1997
Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA)U Specks, E M Wiegert, H A HomburgerThe American Review of Respiratory Disease|January 1, 1990
Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseasesU Specks, W J Martin, M S RohrbachPageof 13